#EurFMT extends its warmest season’s greetings with best wishes for a joyful and successful New Year!

Donor screening for #FMT gets ever more complicated, but is there rationale for this? Great to play a part in this critical appraisal and international Delphi process on this issue, now out in @Gut_BMJ: gut.bmj.com/content/early/… @EdKuijper2 @IHepatology @ImperialMDR @EurFmt

A really important project, bringing together amazing clinical and scientific expertise, trying to raise standards of #FMT throughout Europe and beyond @ehmsg @EurFmt @ImperialMDR #EU4Health

Kick-off the #HARMONIZE guideline meeting on FMT at the EHMSG conference in Rome!
#EU4health #EurFMT

An excellent start in the exciting field of #microbiota at #EHMSG2025 in Rome! Great opportunity to engage in both clinical and scientific exchange with colleagues and friends, and continued collaboration and discovery!
#EHMSG #Hpylori #eurFMT

Are you a basic scientist interested in pathogenesis in digestive diseases?

Be part of the DDM Summit, a basic research initiative during the #UEGweek in October 2025!

Share your research! Submit your abstract!

ueg.eu/week/programme…
@my_ueg @EAGEN_org @EurFmt

#WhatsNewOnFMT #CDI
❓Real-world efficacy of FMT for 1 and 2 CDI

📜n=467 multicentre study from Denmark
56% severe CDI
36% antibiotic-refractory CDI
19 fulminant CDI

✅Overall cure rate 79%
✅90-day mortality: 10%

cghjournal.org/article/S1542-…

Excellent review, coordinated by Silvia Corcione and Benjamin Davido on behalf of ESGHAMI! @EurFmt @SmitsLab @DrBenechNicolas @QuintenDucarmon @LancetMicrobe

How can the gut microbiome be targeted to fight multidrug-resistant or... sciencedirect.com/science/articl…

#WhatsNewOnFMT
#FMTinUC
Guidance for Fecal Microbiota Transplantation Trials in Ulcerative Colitis: The Second ROME Consensus Conference

👉Addresses gaps and uncertainties identified in previous FMT research to help standardise methods and protocols for treating UC in the mcl0bqcb7

#FMT for #HepaticEncephalopathy in #Cirrhosis

Phase 2 Study placebo-controlled, double-blind, clinical trial: capsule and enema FMT
👉FMT is safe
👉Reduces recurrence of HE
👉Effect was independent of route of administration
👉Correlates with Lachnospiraceae

👏@JasmohanBajaj
E

Dear #EurFMT-Network, Colleagues, and Friends,
On behalf of EurFMT-Boards, we wish you all the joys of the Christmas season and a prosperous New Year!

On 12 December, ESGHAMI will organize a webinar entitled “FAECAL MICROBIOTA TRANSPLANTATION (FMT); Its services for Clostridioides difficile infections and other challenges”. @EurFmt @ESCMID
Time: 4 to 5 pm

⚡️International consensus statement on microbiome testing in clinical practice

Congratulations to @gianluca1aniro for leading, and to all coauthors and collaborators for contributing to these much-needed, clinically relevant consensus recommendations!

👉authors.elsevier.com/c/1kDP5_u7c5KU…

Amazing to see such a great participation and interaction at the #EurFMT General Assembly in Vienna during #UEGWeek 2024!

EHMSG - an excellent opportunity for interaction and networking on microbiota, FMT, Helicobacter infection, gastric cancer and much more!

It was great to catch up with friends and colleagues in Porto!

4th General Assembly #EurFMT
October 12, 2024 in Vienna

Topic: FMT landscape in EU, SoHo regulation etc.

If you are interested in attending the meeting - there are only a few places left!
Please use the email pre-registration 👇!

Join us at the 37th Workshop of the European Helicobacter and Microbiota Study Group (#EHMSG) held in Porto, Portugal on September 12 - 14, 2024

workshop.ehmsg.org/registration

#WhatsNewOnFMT in children with constipation

Randomized, double-blind, controlled trial
Enema+Placebo vs. Enema +FMT

✅FMT enhances the efficacy of colonic enema and the use of enema-based FMT is a safe and effective method in the treatment of intractable constipation in Tpp3Ov3Nzu

Excited to present our data @ #IHMC2024 on FMT to tackle #AMR in cirrhosis, we see restoration of gut barrier function/immunity, immunometabolisim & with collaboration with @PhaseGenomics we see beneficial bacteriophage remodelling !

#WhatsNewOnFMT in #LiverCirrhosis
Phase 2 data on FMT in patients with hepatic encephalopathy

👉Recurrence of HE was significantly lower with FMT compared to placebo
👉Reduced hospitalization rate
👉Donor-independent effect
👉Oral vs. enema vs. both = similar effect

Excellent tps://t.co/1nICVSiIiz #EASL2024 @EurFmt